Introduction
============

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is a molecular biological method used to measure the levels of gene expression. RT-qPCR is characterized by high simplicity, effectiveness, specificity and sensitivity ([@b1-mmr-19-05-4377],[@b2-mmr-19-05-4377]). However, the absolute measures derived from RT-qPCR analyses may be affected by multiple factors, including the initial loading amount of RNA, the RNA quality and integrity, the efficiency of the enzymes used in RT-qPCR and the discrepancy in the expression levels of various RNAs between tissues and cells ([@b3-mmr-19-05-4377]). To obtain reliable measurements, it is important to use an internal control gene for normalization. Housekeeping genes are genes involved in fundamental biological processes and are frequently expressed at constant levels in various cell types ([@b4-mmr-19-05-4377],[@b5-mmr-19-05-4377]). Therefore, housekeeping genes are frequently used as internal controls for the normalization of gene expression. However, accumulating evidence has demonstrated that the endogenous expression levels of various housekeeping genes may be variable under certain physiological and pathological conditions and, to the best of our knowledge, no housekeeping gene exhibits a stable expression level under every condition ([@b6-mmr-19-05-4377]--[@b8-mmr-19-05-4377]).

Peripheral nerve injury is a clinical disorder that affects 13--23 patients per 100,000 per year in developed countries ([@b9-mmr-19-05-4377]). Following nerve injury, peripheral nerves undergo multiple regenerative processes including Wallerian degeneration of the distal nerve stump, the regrowth and regeneration of axons, and reinnervation ([@b10-mmr-19-05-4377]). Our previous high-throughput study identified that the expression levels of multiple housekeeping genes were differentially expressed in injured sciatic nerve samples and dorsal root ganglion (DRG) samples following rat sciatic nerve injury, and suitable reference genes for RT-qPCR normalization were selected ([@b11-mmr-19-05-4377]--[@b13-mmr-19-05-4377]).

In addition to peripheral nerves and neurons, target skeletal muscles may exhibit denervation and reinnervation following peripheral nerve injury. The denervation and reinnervation processes are involved in the preservation of the biological functions of innervated muscles ([@b14-mmr-19-05-4377],[@b15-mmr-19-05-4377]). Gene expression analyses are frequently used to investigate the denervation and reinnervation processes of target muscles. Therefore, it is important to identify suitable reference genes in innervated muscles following nerve injury.

Therefore, in the present study, a rat sciatic nerve crush model was employed. Subsequently, gastrocnemius muscles were collected and the cycle quantification (Cq) values of 18S ribosomal RNA (18S), actin β (ACTB), ankyrin repeat domain 27 (ANKRD27), cyclophilin A (CYPA), GAPDH, hypoxanthine phosphoribosyltransferase 1 (HPRT1), mitochondrial ribosomal protein L10 (MRPL10), phosphoglycerate kinase 1 (PGK1), RPTOR independent companion of mammalian target of rapamycin complex 2 (RICTOR), TATA-box binding protein (TBP), ubiquitin C (UBC), UBX domain protein 11 (UBXN11) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein ζ (YWHAZ) were measured. The expression level of HPRT1 exhibited the highest stability among the housekeeping genes analyzed in the present study, whereas PGK1 exhibited the highest variability.

Materials and methods
=====================

### Animal surgery

A total of 30 female Sprague-Dawley rats (age, 2 months; weight, 180--220 g) were purchased from The Experimental Animal Center of Nantong University (Nantong, China) and subjected to sciatic nerve crush injury as previously described ([@b11-mmr-19-05-4377]). Rats were anaesthetized by injecting 2 ml/kg Equithesin (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), as previously described ([@b12-mmr-19-05-4377]), corresponding to 17 mg/kg sodium pentobarbital, 42 mg/kg magnesium sulfate and 85 mg/kg trichloroacetaldehyde monohydrate) ([@b11-mmr-19-05-4377],[@b16-mmr-19-05-4377]). Anesthesia was assessed by loss of pedal reflexes. Rat left sciatic nerves were crushed with forceps for 10 sec, three times. To minimize the discomfort and possible painful mechanical stimulation, the rats were housed in large cages with sawdust bedding post-surgery and maintained in a controlled environment under constant temperature of 25°C and relative humidity of 40--70%, with a 12 h light/dark cycle and free access to food and water. Rats were sacrificed 24 h, 4 days, or 1, 2, 3, 4 or 8 weeks following surgery. Gastrocnemius muscles from the left (injured) side and the right (uninjured) side were collected. Control rats were anesthetized without sciatic nerve crushing (sham surgery). All animal procedures were ethically approved by The Administration Committee of Experimental Animals of The Jiangsu Province (Jiangsu, China).

### Compound muscle action potential (CMAP) recording

CMAP recording was performed at 1, 2, 4 and 8 weeks following surgery. Following anesthesia, the left sciatic nerves of the rats were analyzed. The active and reference electrodes were placed into the medial belly and Achilles tendon of gastrocnemius, respectively. The stimulating electrode was placed sequentially in the proximal and distal sciatic nerves. A 2-mA electric stimulus was applied to the stimulating electrode to stimulate CMAP responses. CMAP readings at the proximal and distal sides were recorded using a portable digital MYTO electromyographic machine (Esaote SpA, Genoa, Italy) with Galileo NT System Software (EB Neuro SpA, Florence, Italy).

### Muscle weight measurement

Gastrocnemius muscles on the left (injured) side and the right (uninjured) side were collected and weighed in healthy control rats and nerve-injured rats at 24 h, 4 days, or 1, 2, 3, 4 or 8 weeks following nerve crush injury. The wet weight of the muscle on the left side was divided by the wet weight of the muscle on the right side to calculate the ratio of injured to uninjured muscle wet weight.

### Immunohistochemistry staining and Masson\'s trichrome staining

Left-side gastrocnemius muscles were collected and fixed in 4% paraformaldehyde for 12 h at 4°C, embedded in Tissue-Tek^®^ optimal cutting temperature compound (Sakura Finetek USA, Inc., Torrance, CA, USA), and cut into 25-µm thick longitudinal sections using a cryostat microtome at −15°C (Leica Microsystems GmbH, Wetzlar, Germany). Sections were washed with PBS, blocked with normal goat serum (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 1 h at 37°C and incubated with anti-neurofilament H (NEFH) antibody (1:200; cat. no. SAB4200747; Sigma-Aldrich; Merck KGaA) overnight at 4°C. Tissue sections were washed, incubated with secondary antibodies conjugated with Alexa Fluor 488 (1:400; cat. no. ab150113; Abcam, Cambridge, MA, USA) and tetramethylrhodamine-labeled α-Bungarotoxin (1:300; cat. no. 203980; Sigma-Aldrich; Merck KGaA) for 2 h at room temperature and observed under a fluorescence microscope at ×100 magnification (Axio Imager M2; Carl Zeiss AG, Oberkochen, Germany).

In addition, after fixation in 4% paraformaldehyde for 12 h at 4°C, gastrocnemius muscles were embedded in paraffin and cut into transverse sections (6-µm thick). Tissue sections were subjected to Masson\'s trichrome staining at room temperature for about 1 h, to stain muscle fibers in red, collagen fibers in blue and cell nuclei in black, and observed using light microscopy at ×200 magnification (Axio Imager M2; Carl Zeiss AG, Oberkochen, Germany). Fiber cross-sectional area (CSA) was calculated using Leica QWin version 3 Image Analysis System Software (Leica Microsystems GmbH).

### RT-qPCR

Total RNA was isolated from left-side gastrocnemius muscles using TRIzol^®^ Reagent (Thermo Fisher Scientific, Inc.), purified with RNeasy spin columns (Qiagen, Inc., Valencia, CA, USA) to remove DNA and reverse transcribed to cDNA with the PrimeScript reagent kit, 37°C for 15 min and 85°C for 5 sec, according to the manufacturer\'s protocol (Takara Biotechnology Co., Ltd., Dalian, China). RT-qPCR was performed using the QuantiNova SYBR Green PCR kit (Qiagen, Inc.) and the StepOne™ real-time PCR System (Applied Biosystems; Thermo Fisher Scientific, Inc.). An initial denaturation of 10 min at 95°C was followed by 40 cycles of 95°C for 15 sec and 60°C for 30 sec. The Cq values for the candidate reference genes 18S, ACTB, ANKRD27, CYPA, GAPDH, HPRT1, MRPL10, PGK1, RICTOR, TBP, UBC, UBXN11 and YWHAZ were determined for subsequent geNorm and NormFinder analyses. The Cq values for the target genes F-box protein 32 (FBXO32) and tripartite motif containing 63 (TRIM63) were additionally assessed and the expression levels of FBXO32 and TRIM63 were calculated using the 2^−ΔΔCq^ method ([@b17-mmr-19-05-4377]). The quality of the RT-qPCR analysis was confirmed by a single melt-curve peak, representing a single amplification product. Primer sequences (listed in [Table I](#tI-mmr-19-05-4377){ref-type="table"}) were obtained from previous publications ([@b18-mmr-19-05-4377]--[@b23-mmr-19-05-4377]) or designed using Primer Express^®^ software (v3.0.1; Thermo Fisher Scientific, Inc.).

### PCR amplification efficiency analysis

The amplification efficiency analysis was performed by producing serial dilutions of the DNA sample. Subsequently, the Cq values were plotted on a logarithmic scale along with corresponding concentrations. Using a linear regression curve through, the slope of the trend line was calculated. Finally, efficiency was defined using the equation: E=−1+10^(−1/slope)^. Typically, desired amplification efficiencies range from 90 to 110% (<https://biosistemika.com/blog/qpcr-efficiency-over-100/>).

### geNorm and NormFinder analysis

Cq values for candidate reference genes were subjected to geNorm analysis (v3.4; <http://genorm.cmgg.be/>), a Visual Basic for plug-in for Microsoft Excel 2007 (Microsoft Corporation, Redmond, WA, USA), that was used to calculate the stability of the expression levels of the reference genes. Gene expression stability (M value) was determined on the basis of non-normalized expression levels of internal reference genes according to a previous study ([@b6-mmr-19-05-4377]). The normalization factor (pairwise variation value, Vn/n+1) was calculated based on the geometric mean of multiple reference genes ([@b6-mmr-19-05-4377]). The stability values of candidate reference genes were also measured using the NormFinder analysis (v19, <http://moma.dk/normfinder-software>), a model-based variance estimation approach of Microsoft Excel (Microsoft Corporation), according to a previous study ([@b3-mmr-19-05-4377]).

### Statistical analysis

Data are presented as the mean ± standard deviation. Each independent experiment was repeated three times. Statistical analysis was performed using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). The linear association between two variables was assessed by calculating the correlation coefficient R^2^, ranging from 0 to 1. Differences between rats in the injury and normal control groups were tested using one-way analysis of variance followed by Dunnett\'s multiple comparisons test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Gastrocnemius muscles exhibit denervation and reinnervation following sciatic nerve crush injury

To investigate muscle denervation and reinnervation, morphological and physiological parameters of gastrocnemius muscles were examined in normal control rats and in rats subjected to sciatic nerve injury. Staining of the axon marker NEFH and the motor end-plate marker α-Bungarotoxin ([Fig. 1A](#f1-mmr-19-05-4377){ref-type="fig"}) were detected, and the structure of muscle fibers ([Fig. 1B](#f1-mmr-19-05-4377){ref-type="fig"}) appeared to be intact. Furthermore, normal CMAP amplitude ([Fig. 1C](#f1-mmr-19-05-4377){ref-type="fig"}) was observed in the gastrocnemius muscles of uninjured rats. At 1 week following sciatic nerve injury, degenerated axon fragments were not present, and axons were not detectable between muscle fibers ([Fig. 1D](#f1-mmr-19-05-4377){ref-type="fig"}), muscle fibers were atrophied ([Fig. 1E](#f1-mmr-19-05-4377){ref-type="fig"}) and CMAP was not be detected ([Fig. 1F](#f1-mmr-19-05-4377){ref-type="fig"}). At 2 weeks following sciatic nerve injury, a small number of regenerated axons were observed, and a subset of axons initiated reinnervation ([Fig. 1G](#f1-mmr-19-05-4377){ref-type="fig"}). Masson\'s trichrome staining results suggested the presence of muscle atrophy and a large number of hyperplastic collagen fibers were observed ([Fig. 1H](#f1-mmr-19-05-4377){ref-type="fig"}). Low CMAP amplitude was recorded ([Fig. 1I](#f1-mmr-19-05-4377){ref-type="fig"}) at 2 weeks following injury. Multiple regenerated axons and reinnervated fibers were observed at 4 weeks following nerve injury ([Fig. 1J](#f1-mmr-19-05-4377){ref-type="fig"}). Additionally, muscle atrophy ([Fig. 1K](#f1-mmr-19-05-4377){ref-type="fig"}) and CMAP ([Fig. 1L](#f1-mmr-19-05-4377){ref-type="fig"}) were partially recovered. At 8 weeks following sciatic nerve injury, the number of regenerated axons and reinnervated fibers increased ([Fig. 1M](#f1-mmr-19-05-4377){ref-type="fig"}), the morphology of muscles ([Fig. 1N](#f1-mmr-19-05-4377){ref-type="fig"}) and the CMAP profile ([Fig. 1O](#f1-mmr-19-05-4377){ref-type="fig"}) were similar to the control rats ([Fig. 1A-C](#f1-mmr-19-05-4377){ref-type="fig"}).

Additionally, the ratio of injured to uninjured muscle wet weight decreased significantly following nerve injury at week 1 and 2, and improved at 4 and 8 weeks ([Fig. 1P](#f1-mmr-19-05-4377){ref-type="fig"}). CSA exhibited a similar trend ([Fig. 1Q](#f1-mmr-19-05-4377){ref-type="fig"}), suggesting that the gastrocnemius muscles underwent muscle atrophy following nerve injury. Quantification of the CMAP results suggested that the decreased CMAP amplitude detected at 2 weeks was increased at 4 weeks following nerve injury and was restored to normal levels at 8 weeks following injury ([Fig. 1R](#f1-mmr-19-05-4377){ref-type="fig"}). Collectively, the present data suggested that the physiological functions of muscles were gradually restored during the process of reinnervation of target muscles.

### Cq values of reference genes in gastrocnemius muscles following sciatic nerve crush injury

Prior to the determination of the Cq values of the reference genes, the efficiencies of the primers selected for RT-qPCR were examined. Following a serial dilution, the amplifications of the 13 candidate housekeeping genes exhibited linear standard curves with slope values of \~-3.322 and a linear correlation coefficient (R^2^) of \~1 ([Table II](#tII-mmr-19-05-4377){ref-type="table"}). The amplification efficiencies of the primer pairs of all housekeeping genes were calculated based on the slope of the linear standard curves. The amplification efficiencies of all primer pairs were between 90 and 102% ([Table II](#tII-mmr-19-05-4377){ref-type="table"}).

Subsequently, RT-qPCR experiments were performed to measure the raw Cq values of the reference genes. 18S exhibited the lowest Cq value, indicating that the abundance of 18S ribosomal RNA gene was the highest in rat gastrocnemius muscles. The Cq values of GAPDH, a gene encoding an enzyme involved in glycolysis, were decreased compared with other genes. The Cq values of UBXN11 were increased compared with other housekeeping genes, suggesting that its endogenous expression level was the lowest. The Cq values of the other housekeeping genes ranged between 20 and 30 ([Fig. 2](#f2-mmr-19-05-4377){ref-type="fig"}). In addition, the Cq values of the housekeeping genes in gastrocnemius muscles were assessed at various time points following sciatic nerve injury. The Cq values of ANKRD27, HPRT1, MRPL10, RICTOR and TBP exhibited a stable level in normal control rats and nerve-injured rats at various time points. By contrast, the Cq values of 18S, ACTB, CYPA, GAPDH, PGK1, UBC, UBXN11 and YWHAZ exhibited variability among time points ([Fig. 2](#f2-mmr-19-05-4377){ref-type="fig"}).

### Reference gene HPRT1 exhibits high stability

The stabilities of the gene expression levels of the candidate reference genes were examined using geNorm analysis. Average expression stability was calculated and M values were assigned to each reference gene. The M value calculated for each gene was inversely proportional to the stability of the expression level of the corresponding gene. Our previous study identified that all reference genes examined exhibited M\<1.5, corresponding to the default limit ([@b6-mmr-19-05-4377]). The reference genes ANKRD27 and HPRT1 exhibited decreased M values compared with the other reference genes, suggesting that the expression levels of these two reference genes were the most stable ([Fig. 3A](#f3-mmr-19-05-4377){ref-type="fig"}). PGK1 presented the highest M value, corresponding to the lowest stability ([Fig. 3A](#f3-mmr-19-05-4377){ref-type="fig"}). The normalization factor (pairwise variation value, V~n/n+1~) was calculated to assess the optimal numbers of reference genes to use for gene expression normalization. The pairwise variation value V~2/3~ calculated was 0.103, below the default limit of V~n/n+1~=0.15 ([@b24-mmr-19-05-4377]), suggesting that the two reference genes ANKRD27 and HPRT1 were sufficient to normalize gene expression levels in rat gastrocnemius muscles ([Fig. 3B](#f3-mmr-19-05-4377){ref-type="fig"}).

The stabilities of the expression levels of the reference genes were further analyzed and ranked using NormFinder. Low stability values were associated with stable expression levels. NormFinder analysis suggested that HPRT1 was the reference gene with the most stable expression level, followed by ANKRD27. The expression level of PGK1 exhibited the lowest stability among the genes examined ([Fig. 4](#f4-mmr-19-05-4377){ref-type="fig"}). The NormFinder results were consistent with the geNorm results. Collectively, the present results suggested that, in rat gastrocnemius muscles following sciatic nerve injury, the expression levels of HPRT1 and PGK1 exhibited the highest and the lowest stability, respectively.

### Determination of gene expression levels is influenced by normalization genes

The influence of distinct reference genes was examined by determining the expression levels of FBXO32 and TRIM63, two genes encoding skeletal muscle atrophy markers ([@b23-mmr-19-05-4377],[@b25-mmr-19-05-4377],[@b26-mmr-19-05-4377]). The primer pairs of FBXO32 and TRIM63 exhibited linear standard curves with high efficiency values (94 and 95%, respectively; [Table II](#tII-mmr-19-05-4377){ref-type="table"}). HPRT1 and PGK1 exhibited the lowest and the highest stability, respectively. Therefore, these two genes were used as internal controls to perform RT-qPCR experiments ([Fig. 5](#f5-mmr-19-05-4377){ref-type="fig"}).

Using HPRT1 as the internal control, the expression levels of FBXO32 were observed to be significantly upregulated in rat gastrocnemius muscles following sciatic nerve injury, exhibiting a maximum at 1 day following injury ([Fig. 5A](#f5-mmr-19-05-4377){ref-type="fig"}). Similarly, using PGK1 as internal control, the expression levels of FBXO32 were observed to be upregulated following nerve injury. However, the highest Cq value of FBXO32 was detected at 1 week following injury. Notably, the fold changes of FBXO32 were identified to vary depending on the reference gene selected ([Fig. 5B](#f5-mmr-19-05-4377){ref-type="fig"}).

Results from geNorm analysis suggested that two reference genes were sufficient to normalize gene expression levels. In addition to HPRT1, ANKRD27 and TBP were identified to exhibit stable expression levels. Therefore, the geometric mean of ANKRD27 and TBP was used as an internal control ([Fig. 5C and F](#f5-mmr-19-05-4377){ref-type="fig"}). Using ANKRD27+TBP or HPRT1 as the internal controls did not affect the detected expression level of FBXO32, which exhibited similar fold changes at all time points following peripheral nerve injury ([Fig. 5C](#f5-mmr-19-05-4377){ref-type="fig"}).

Additionally, TRIM63 exhibited similar expression patterns at various time points following sciatic nerve injury, regardless of the reference gene selected ([Fig. 5D-F](#f5-mmr-19-05-4377){ref-type="fig"}). However, similarly to FBXO32, the calculated relative fold changes of TRIM63 varied depending on the reference gene selected. The expression level of TRIM63 at 4 days following nerve injury increased by \~5 fold when compared with normal control, using HPRT1 or ANKRD27+TBP as the internal control ([Fig. 5D and F](#f5-mmr-19-05-4377){ref-type="fig"}). By contrast, using PGK1 as the internal control, the detected relative expression level of TRIM63 at 4 days following nerve injury increased by \~30 folds when compared with the normal control ([Fig. 5E](#f5-mmr-19-05-4377){ref-type="fig"}).

Discussion
==========

The denervation and reinnervation of target skeletal muscles is a biological process that occurs following peripheral nerve injury ([@b10-mmr-19-05-4377]). Muscle denervation leads to muscle atrophy that is characterized by reduced muscle mass, altered muscle morphology and impaired muscle functions including decreased force production and power output ([@b27-mmr-19-05-4377]--[@b29-mmr-19-05-4377]). Clinical trials have demonstrated that reinnervation may reduce muscle atrophy and promote the recovery of muscle function. By contrast, prolonged muscle denervation may cause irreversible damage ([@b30-mmr-19-05-4377],[@b31-mmr-19-05-4377]).

Incomplete and/or delayed peripheral nerve reinnervation and consequent impaired muscle function remains a major health problem. Therefore, multiple previous studies investigated the alterations in gene expression during the process of muscle denervation and reinnervation following peripheral nerve injury, with the aim to identify novel therapeutic targets to treat patients with injury-induced muscle atrophy ([@b32-mmr-19-05-4377]--[@b35-mmr-19-05-4377]). Microarray analysis, a high-throughput method that allows parallel analysis of multiple samples, was used to identify gene expression profiles during muscle denervation and reinnervation ([@b32-mmr-19-05-4377],[@b36-mmr-19-05-4377]). The expression levels of microRNAs and their target genes were also examined in the context of muscle reinnervation ([@b37-mmr-19-05-4377]--[@b39-mmr-19-05-4377]). The accuracy of the results derived from high-throughput approaches is frequently confirmed by RT-qPCR analysis. Therefore, the selection of suitable internal controls is required to decrease the inaccuracy derived by alterations in the expression levels of the reference gene and to increase the reliability of the RT-qPCR results.

In the present study, the morphological and physiological parameters in the gastrocnemius muscles were investigated in normal control rats and in rats following sciatic nerve crush injury, and structural and functional alterations were observed in the gastrocnemius muscles following nerve injury. Therefore, a great number of genes, including housekeeping genes, may be differentially expressed in gastrocnemius muscles during these biological processes. To examine the possibility that the expression levels of housekeeping genes may be affected, primer pairs with high efficiency were used and the raw Cq values of 13 housekeeping genes were measured in the control and injured rats. A subset of housekeeping genes, including 18S, ACTB, CYPA, GAPDH, PGK1, UBC, UBXN11 and YWHAZ, exhibited variable Cq values. The present results suggested that certain housekeeping genes may not exhibit stable expression levels in rat gastrocnemius muscles following sciatic nerve injury, further confirming the importance of the identification of a suitable reference gene to study this process.

By using geNorm and NormFinder analyses, the stabilities of these housekeeping genes were assessed. By using geNorm analysis, the housekeeping genes with the most stable expression levels were selected based on their expression level ratios ([@b2-mmr-19-05-4377],[@b6-mmr-19-05-4377]), and ANKRD27 and HPRT1 were identified to exhibit stable expression levels. By using NormFinder analysis, the gene expression variation and the similarities among expression profiles of the housekeeping genes were calculated ([@b3-mmr-19-05-4377]), and the expression level of HPRT1 was identified as the most stable among the reference genes examined. geNorm and NormFinder results suggested that HPRT1 was the most suitable internal reference gene, whereas PGK1 was not a reliable internal control. RT-qPCR experiments were performed to analyze the expression profiles of FBXO32 and TRIM63 using various reference genes, in order to investigate whether the selection of a certain housekeeping gene may affect the quantification results. RT-qPCR results demonstrated that the expression patterns and fold changes of the examined target genes varied using the stable housekeeping gene HPRT1 or the unstable housekeeping gene PGK1 as the reference gene. Furthermore, the standard deviation values of target genes increased with PGK1 as the internal control. The present results suggested that the selection of the reference gene may influence experimental reproducibility. However, the genomic locus of HPRT1 presents pseudogenes ([@b40-mmr-19-05-4377]), and the quantification of HPRT1 may be affected by genomic DNA contamination, despite treatment with DNase. Therefore, additional housekeeping genes with stable expression levels, including ANKRD27 and TBP, may be used. In the present study, the geometric mean of ANKRD27 and TBP was used to normalize the expression levels of FBXO32 and TRIM63. Quantitative results suggested that FBXO32 and TRIM63 exhibited similar temporal dynamics using HPRT1 or ANKRD27+TBP as the internal control, suggesting that ANKRD27+TBP may additionally be used as a suitable control.

Selection of suitable internal controls was previously identified to be involved in the accuracy of gene quantification. The selection of the most suitable reference gene was identified to be cell- and tissue-specific ([@b2-mmr-19-05-4377],[@b22-mmr-19-05-4377],[@b41-mmr-19-05-4377],[@b42-mmr-19-05-4377]). Our previous study suggested that distinct reference genes may be selected in sciatic nerve samples and DRG samples following rat sciatic nerve crush injury ([@b13-mmr-19-05-4377]). In the present study, by using geNorm and NormFinder algorithms, the stabilities of the gene expression of 13 housekeeping genes were investigated, and HPRT1 was identified as the most stable housekeeping gene in gastrocnemius muscles following rat sciatic nerve crush injury. The present results suggested that the selection of an appropriate internal control is required for reliable gene normalization. Furthermore, the results of the present study may provide insights that may be beneficial for future studies aiming to analyze gene expression in innervated muscles following peripheral nerve injury.
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![Morphological and electrophysiological alterations in rat gastrocnemius muscles following sciatic nerve crush injury. Gastrocnemius muscles of control rats were analyzed using (A) immunohistochemistry, (B) Masson\'s trichrome staining and (C) CMAP recording. Gastrocnemius muscles at 1 week following sciatic nerve injury were analyzed using (D) immunohistochemistry, (E) Masson\'s trichrome staining and (F) CMAP recording. Gastrocnemius muscles at 2 weeks following sciatic nerve injury were analyzed using (G) immunohistochemistry, (H) Masson\'s trichrome staining and (I) CMAP recording. Gastrocnemius muscles at 4 week following sciatic nerve injury were analyzed using (J) immunohistochemistry, (K) Masson\'s trichrome staining and (L) CMAP recording. Gastrocnemius muscles at 8 weeks following sciatic nerve injury were analyzed using (M) immunohistochemistry, (N) Masson\'s trichrome staining and (O) CMAP recording. Immunohistochemistry was performed using anti-neurofilament H (green) and α-Bungarotoxin (red); scale bars, 100 µm. Tissue sections were subjected to Masson\'s trichrome staining to stain muscle fibers in red, collagen fibers in blue and cell nuclei in black; scale bar, 50 µm. (P) Ratio of injured to uninjured muscle wet weight (n=4 in each group) measured in various groups. (Q) CSA (n=4 in each group) in various groups. (R) CMAP amplitude (n=4 in each group) in various groups. \*\*P\<0.01 and \*\*\*P\<0.001 vs. corresponding control. CMAP, compound muscle action potential; CSA, cross-sectional area; Con, control.](MMR-19-05-4377-g00){#f1-mmr-19-05-4377}

![Raw Cq values of candidate reference genes in gastrocnemius muscles. The Cq values of 18S, ACTB, ANKRD27, CYPA, GAPDH, HPRT1, MRPL10, PGK1, RICTOR, TBP, UBC, UBXN11 and YWHAZ in normal control rats and rats subjected to sciatic nerve injury 1, 2, 4 or 8 weeks following injury were assessed by reverse transcription-quantitative polymerase chain reaction (n=3 in each group). 18S, 18S ribosomal RNA; ANKRD27, ankyrin repeat domain 27; CYPA, cyclophilin A; HPRT1, hypoxanthine phosphoribosyltransferase 1; MRPL10, mitochondrial ribosomal protein L10; PGK1, phosphoglycerate kinase 1; RICTOR, RPTOR independent companion of mammalian target of rapamycin complex 2; TBP, TATA-box binding protein; UBC, ubiquitin C; UBXN11, UBX domain protein 11; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein ζ; ACTB, actin β.](MMR-19-05-4377-g01){#f2-mmr-19-05-4377}

![Analysis of candidate reference genes using geNorm. (A) Average expression stability of 18S, ACTB, ANKRD27, CYPA, GAPDH, HPRT1, MRPL10, PGK1, RICTOR, TBP, UBC, UBXN11 and YWHAZ. M values are inversely proportional to the stability of the expression levels of the corresponding genes. (B) Normalization factor (pairwise variation value, Vn/n+1) was calculated to assess the optimal numbers of reference genes to use for gene expression normalization. ANKRD27, ankyrin repeat domain 27; CYPA, cyclophilin A; HPRT1, hypoxanthine phosphoribosyltransferase 1; MRPL10, mitochondrial ribosomal protein L10; PGK1, phosphoglycerate kinase 1; RICTOR, RPTOR independent companion of mammalian target of rapamycin complex 2; TBP, TATA-box binding protein; UBC, ubiquitin C; UBXN11, UBX domain protein 11; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein ζ; ACTB, actin β.](MMR-19-05-4377-g02){#f3-mmr-19-05-4377}

![Analysis of candidate reference genes using NormFinder. Stability values of 18S, ACTB, ANKRD27, CYPA, GAPDH, HPRT1, MRPL10, PGK1, RICTOR, TBP, UBC, UBXN11 and YWHAZ. Stability values are inversely proportional to the stability of the expression levels of the corresponding genes. 18S, 18S ribosomal RNA; ANKRD27, ankyrin repeat domain 27; CYPA, cyclophilin A; HPRT1, hypoxanthine phosphoribosyltransferase 1; MRPL10, mitochondrial ribosomal protein L10; PGK1, phosphoglycerate kinase 1; RICTOR, RPTOR independent companion of mammalian target of rapamycin complex 2; TBP, TATA-box binding protein; UBC, ubiquitin C; UBXN11, UBX domain protein 11; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein ζ; ACTB, actin β.](MMR-19-05-4377-g03){#f4-mmr-19-05-4377}

![Determination of mRNA expression levels of FBXO32 and TRIM63 in gastrocnemius muscles using HPRT1, PGK1 or ANKRD27+TBP as reference genes. mRNA expression levels of FBXO32 were compared between normal control rats and rats subjected to sciatic nerve injury using (A) HPRT1, (B) PGK1 or (C) ANKRD27+TBP as the reference gene (n=3 in each group). mRNA expression levels of TRIM63 were compared between normal control rats and rats subjected to sciatic nerve injury using (D) HPRT1, (E) PGK1 or (F) ANKRD27+TBP as the reference gene (n=3 in each group). \*P\<0.05, \*\*P\<0.01 and \*\*\*P\<0.001 vs. Con. HPRT1, hypoxanthine phosphoribosyltransferase 1; PGK1, phosphoglycerate kinase 1; FBXO32, F-box protein 32; TRIM63, tripartite motif containing 63; ANKRD27, ankyrin repeat domain 27; TBP, TATA-box binding protein; Con, normal control rats.](MMR-19-05-4377-g04){#f5-mmr-19-05-4377}

###### 

Primer sequences of candidate housekeeping reference genes and target genes.

  A, Reference genes                                                                                                                                              
  --------------------------------- ----------------- -------------------------------------- --------------------------------- ---------------------------------- --------------------------------------------------
  Martínez-Martos, *et al*, 2018    18S               X01117.1                               Fw: ACTCAACACGGGAAACCTCA          114                                ([@b16-mmr-19-05-4377])
                                                                                             Rv: AATCGCTCCACCAACTAAGA                                             
  Bangaru *et al*, 2012             ACTB              NM_031144.2                            Fw: TGTCACCAACTGGGACGATA          165                                ([@b18-mmr-19-05-4377])
                                                                                             Rv: GGGGTGTTGAAGGTCTCAAA                                             
  Bonefeld *et al*, 2008            ANKRD27           NM_001271264.1                         Fw: CCCAGGATCCGAGAGGTGCTGTC       95                                 ([@b19-mmr-19-05-4377])
                                                                                             Rv: CAGAGCCATATGGACTTCAGGGGG                                         
  Martínez-Martos, *et al*, 2018    CYPA              NM_017101.1                            Fw: CCAAACACAAATGGTTCCCAGT        135                                ([@b16-mmr-19-05-4377])
                                                                                             ATTCCTGGACCCAAAACGCT                                                 
  Bonefeld *et al*, 2008            GAPDH             NM_017008.4                            Fw: CCACCAACTGCTTAGCCCCC          91                                 ([@b19-mmr-19-05-4377])
                                                                                             Rv: GCAGTGATGGCATGGACTGTGG                                           
  Gambarotta *et al*, 2014          HPRT1             NM_012583.2                            Fw: CTCATGGACTGATTATGGACAGGAC     123                                ([@b20-mmr-19-05-4377])
                                                                                             Rv: GCAGGTCAGCAAAGAACTTATAGCC                                        
  Bonefeld *et al*, 2008            MRPL10            NM_001109620.1                         Fw: CTCCTCCCAAGCCCCCCAAG          97                                 ([@b19-mmr-19-05-4377])
                                                                                             Rv: CAGACAGCTATCATTCGGTTGTCCC                                        
  Peinnequin *et al*, 2004          PGK1              NM_053291.3                            Fw: GCAGATTGTTTGGAACGGTCC         113                                ([@b21-mmr-19-05-4377])
                                                                                             Rv: TAGTGATGCAGCCCCTAGACGT                                           
                                    RICTOR            XM_001055633.3                         Fw: TCCGAATACGAGGGCGGAA           142                                ^[a](#tfn1-mmr-19-05-4377){ref-type="table-fn"}^
                                                                                             Rv: AGATGGCCCAGCTTTCTCATA                                            
  Peinnequin *et al*, 2004          TBP               NM_001004198.1                         Fw: TAATCCCAAGCGGTTTGCTG          111                                ([@b21-mmr-19-05-4377])
                                                                                             Rv: TTCTTCACTCTTGGCTCCTGTG                                           
  Bonefeld *et al*, 2008            UBC               NM_017314.1                            Fw: TCGTACCTTTCTCACCACAGTATCTAG   82                                 ([@b19-mmr-19-05-4377])
                                                                                             Rv: GAAAACTAAGACACCTCCCCATCA                                         
  Bonefeld *et al*, 2008            UBXN11            NM_138853.2                            Fw: GCGAGACTGGATGAAGGCCAAG        120                                ([@b19-mmr-19-05-4377])
                                                                                             Rv: CCCTCCACCACCAGCTCACTC                                            
  Bangaru *et al*, 2012             YWHAZ             NM_013011.3                            Fw: TTGAGCAGAAGACGGAAGGT          136                                ([@b18-mmr-19-05-4377])
                                                                                             Rv: GAAGCATTGGGGATCAAGAA                                             
                                                                                                                                                                  
  **B, Target genes**                                                                                                                                             
                                                                                                                                                                  
  **Autdor, year**                  **Gene symbol**   **NCBI transcript accession number**   **Primer sequences (5′-3′)**      **Amplicon length, nucleotides**   **(Refs.)**
                                                                                                                                                                  
  Martínez-Beamonte *et al*, 2011   FBXO32            NM_133521.1                            Fw: CCATCAGGAGAAGTGGATCTATGTT     75                                 ([@b22-mmr-19-05-4377])
                                                                                             Rv: GCTTCCCCCAAAGTGCAGTA                                             
  Martínez-Beamonte *et al*, 2011   TRIM63            NM_080903.1                            Fw: GTGAAGTTGCCCCCTTACAA          66                                 ([@b22-mmr-19-05-4377])
                                                                                             Rv: TGGAGATGCAATTGCTCAGT                                             

primers were designed using Primer Express^®^ software (v3.0.1, Thermo Fisher Scientific, Inc.). 18S, 18S ribosomal RNA; ANKRD27, ankyrin repeat domain 27; CYPA, cyclophilin A; HPRT1, hypoxanthine phosphoribosyltransferase 1; MRPL10, mitochondrial ribosomal protein L10; PGK1, phosphoglycerate kinase 1; RICTOR, RPTOR independent companion of mammalian target of rapamycin complex 2; TBP, TATA-box binding protein; UBC, ubiquitin C; UBXN11, UBX domain protein 11; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein ζ; FBXO32, F-box protein 32; TRIM63, tripartite motif containing 63; ACTB, actin β; NCBI, National Center for Biotechnology Information; Fw, forward; Rv, Reverse.

###### 

Amplification efficiencies of candidate housekeeping genes and target genes.

  A, Reference genes                           
  --------------------- ----------- ---------- --------------------
  18S                   −3.523      0.9994     92
  ACTB                  −3.277      0.9921     102
  ANKRD27               −3.567      0.9976     91
  CYPA                  −3.460      0.9974     95
  GAPDH                 −3.489      0.9998     93
  HPRT1                 −3.505      0.9996     93
  MRPL10                −3.518      0.9920     92
  PGK1                  −3.490      0.9983     93
  RICTOR                −3.507      0.9963     93
  TBP                   −3.558      0.9921     91
  UBC                   −3.433      0.9989     96
  UBXN11                −3.373      0.9994     98
  YWHAZ                 −3.307      0.9975     101
                                               
  **B, Target genes**                          
                                               
  **Gene symbol**       **Slope**   **R^2^**   **Efficiency (%)**
                                               
  FBXO32                −3.463      0.9977     94
  TRIM63                −3.450      0.9999     95

18S, 18S ribosomal RNA; ANKRD27, ankyrin repeat domain 27; CYPA, cyclophilin A; HPRT1, hypoxanthine phosphoribosyltransferase 1; MRPL10, mitochondrial ribosomal protein L10; PGK1, phosphoglycerate kinase 1; RICTOR, RPTOR independent companion of mammalian target of rapamycin complex 2; TBP, TATA-box binding protein; UBC, ubiquitin C; UBXN11, UBX domain protein 11; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein ζ; FBXO32, F-box protein 32; TRIM63, tripartite motif containing 63; ACTB, actin β.

[^1]: Contributed equally
